BPA for pemazyre
Ended Awarded Last action
- Contract number
- 36E79721A0005
- Awardee
-
Incyte Corporation UEI ZTM9U2G5VTK8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 1 $12,725 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $12,725 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $3,750,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Incyte Corporation, a global biopharmaceutical company. The BPA, valued at $3,750,000, is for the supply of Pemazyre (pemigatinib), Incyte's specialized oncology drug used to treat certain types of cancer. The BPA, which runs through November 20, 2025, is issued under Incyte's Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, valued at $541 million.
Under this BPA, Incyte will fulfill delivery orders for Pemazyre tablets in 4.5mg, 9mg, and 13.5mg dosages to VA medical centers and facilities across the United States. A sample $12,725.23 task order was awarded to Incyte by the VA's Veterans Integrated Service Network 22 for the delivery of Pemazyre tablets to support healthcare services for veterans within VISN 22's coverage area. All contract awards have been issued as firm fixed price with no set-aside designations, indicating Incyte competes in the unrestricted federal marketplace for these critical pharmaceutical supply contracts.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pemazyre tabs | Veterans Integrated Service Network 22 (VHA) | $12,725 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0005?
36E79721A0005 was awarded to Incyte Corporation by National Acquisition Center (Headquarters) on November 21, 2020.
How much is contract 36E79721A0005 worth?
Orders under 36E79721A0005 have obligated $12,725. 36E79721A0005's own ceiling is $3,750,000.
How many orders have been placed under contract 36E79721A0005?
1 order has been placed under 36E79721A0005, the latest on August 6, 2021.
Who can order from contract 36E79721A0005?
36E79721A0005 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0005 under another contract?
Yes. 36E79721A0005 is a blanket purchase agreement under 36F79720D0189, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0005 competed?
The extent of competition for 36E79721A0005 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV